SummitTX Capital, L.P.
Position in DNTH — Dianthus Therapeutics, Inc. /DE/
CIK 2052310
FORT WORTH, TX
Position in DNTH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,225,657
-$2,170,035 QoQ
Shares Held
63,866
-36.2% QoQ
Ownership
0.114%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#95
of 269 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNTH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SummitTX Capital, L.P. holds $220,272,212 across 62 Biotechnology names. DNTH ranks #15 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
126,401 | $14,034,303 | |
| 2 | RARE |
Ultragenyx Pharmaceutical Inc.
|
374,270 | $12,496,875 | |
| 3 | CYTK |
Cytokinetics Inc
|
112,893 | $9,617,354 | |
| 4 | CLDX |
Celldex Therapeutics, Inc.
|
254,959 | $9,487,024 | |
| 5 | QTTB |
Q32 Bio Inc.
|
733,774 | $9,348,280 | |
| 6 | GMAB |
Genmab A/S
|
318,408 | $8,746,667 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
36,276 | $8,741,427 | |
| 8 | ABVX |
Abivax S.A.
|
65,216 | $8,690,684 |
All Filings in DNTH
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,225,657 | 63,866 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $8,395,692 | 100,044 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,623,430 | 87,926 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||